Effects of Benson Relaxation Exercise on Anxiety Level and Sleep Quality in Adolescents

NCT ID: NCT06661304

Last Updated: 2024-12-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-31

Study Completion Date

2025-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose: The purpose of this study is to examine the effects of Benson relaxation exercise applied to children and adolescents receiving inpatient treatment in a psychiatric clinic on anxiety levels and sleep quality.

Design: The study is a randomized controlled trial with a pretest-posttest control group.

Method: The study will be conducted in a private psychiatric hospital in Turkey between October 2024 and June 2025. When hospital records were examined, it was determined that 100 patients received inpatient treatment in the last year. Therefore, the universe of the study consisted of 100 patients. The effect of some instructions in the Benson relaxation exercise on delusions and hallucinations is unknown. Therefore, psychosis and schizophrenia patients with delusions and hallucinations will be excluded from the scope of the study. Patients who meet the inclusion criteria will be randomly assigned to the intervention and control groups. The study will be terminated when a total of 60 patients are reached, 30 in the intervention and 30 in the control group. Benson relaxation exercise will be applied to the patients in the intervention group. No application will be made to the patients in the control group. Research data will be collected with the "State-Trait Anxiety Scale" and "Pittsburgh Sleep Quality Index".

Hypotheses:

H1: The anxiety level of patients who applied Benson relaxation exercise is lower than the patients who did not.

H2: The sleep quality of patients who applied Benson relaxation exercise is better than the patients who did not.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Relaxation Program Anxiety Sleep Quality Psychiatric Hospitalization

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BRE

Group Type EXPERIMENTAL

Benson Relaxation Exercise

Intervention Type OTHER

Benson relaxation exercise is based on the patient relaxing their body muscles by focusing on deep breathing and a word that means something to them.

Control

Group Type ACTIVE_COMPARATOR

Ongoing treatment

Intervention Type OTHER

In addition to their medical treatment and care in the clinics, patients participate in activities such as group activities, leisure time and walking.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Benson Relaxation Exercise

Benson relaxation exercise is based on the patient relaxing their body muscles by focusing on deep breathing and a word that means something to them.

Intervention Type OTHER

Ongoing treatment

In addition to their medical treatment and care in the clinics, patients participate in activities such as group activities, leisure time and walking.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being treated in the child and adolescent clinic at the hospital where the study was conducted
* Being between the ages of 14-18
* Not diagnosed with psychotic disorder or schizophrenia
* Scoring between 20 and 59 on the STAI I-II scale
* Scoring 5 and above on the PSQI scale
* Being willing to participate in the study
* Parents giving verbal consent for participation in the study and signing the written voluntary consent form

Exclusion Criteria

* Not receiving treatment in the child-adolescent clinic at the hospital where the study was conducted
* Not being between the ages of 14-18
* Being diagnosed with psychotic disorder and schizophrenia
* Not receiving a score between 20-59 on the STAI I-II scale
* Receiving a score below 5 on the PSQI scale
* Not being willing to participate in the study
* The parent not giving verbal consent for participation in the study and not signing the written voluntary consent form
Minimum Eligible Age

14 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Uskudar University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aydan Akkurt Yalçıntürk

Asst. Prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Uskudar University

Ümraniye, Istanbul, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Aydan Akkurt Yalçıntürk

Role: CONTACT

Phone: +905321392497

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

61351342/020-423

Identifier Type: -

Identifier Source: org_study_id